microbiome.ferring.comThe Power of the Microbiome | Ferring Pharmaceuticals

microbiome.ferring.com Profile

Microbiome.ferring.com is a subdomain of Ferring.com, which was created on 1996-10-20,making it 27 years ago. It has several subdomains, such as yes.ferring.com , among others.

Description:Ferring Pharmaceutical educates about the microbiome and if it can be used to break the cycle of recurrent C. difficile (CDI)...

Keywords:Recurring c. diff treatment, recurrent c. diff treatment, why does c.diff recur, microbiome...

Discover microbiome.ferring.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

microbiome.ferring.com Information

HomePage size: 132.634 KB
Page Load Time: 0.989822 Seconds
Website IP Address: 104.198.98.254

microbiome.ferring.com Similar Website

Aridis Pharmaceuticals - Welcome
investors.aridispharma.com
Clinical Trials | Regeneron Pharmaceuticals
clinicaltrials.regeneron.com
Investor Relations :: CNS Pharmaceuticals, Inc. (CNSP)
ir.cnspharma.com
Mirum Pharmaceuticals, Inc. - Investor Relations
ir.mirumpharma.com
Ferring Home
ferring.icsconnect.com
Ferring – We need your consent
yes.ferring.com
Investor Relations - Supernus Pharmaceuticals
ir.supernus.com
Amneal Pharmaceuticals, Inc. - Investor Relations
investors.amneal.com
Gut Microbiome Testing & Analysis Australia | Microba
insight.microba.com
Investors :: Conatus Pharmaceuticals Inc. (CNAT)
ir.conatuspharma.com
Eagle Pharmaceuticals Investor Center |
investor.eagleus.com
Ferring Scouts
ferringscouts.smugmug.com
GuzziTech.com - Guzzi Power Guzzi Power Guzzi Power Guzzi Power Guzzi Power
archive.guzzitech.com
Lifeline Pharmaceuticals, LLC’s Login Page | Lifeline Pharmaceuticals, LLC
lifelinepharm.tracktracerx.com
SBC Data Power - UPS Emergency Power DC Power Supplies
teamelite.sbcpower.com

microbiome.ferring.com PopUrls

Ferring Pharmaceuticals: The Power of the Microbiome
https://microbiome.ferring.com/
Importance of Microbial Diversity
https://microbiome.ferring.com/microbial-diversity/
About Ferring
https://microbiome.ferring.com/exhibit/about-ferring/
What is C. Diff? Symptoms, Treatment, & Support
https://microbiome.ferring.com/patient-c-diff-infection/
Exhibit Sections
https://microbiome.ferring.com/exhibit/exhibit-sections/
Ferring - The Power of the Microbiome
https://microbiome.ferring.com/reveal/
Microbiome Priority Access and Updates | The Power of ...
https://microbiome.ferring.com/sign-up-for-priority-access-to-updates/
Sign Up for Update
https://microbiome.ferring.com/exhibit/sign-up-for-update/
Get the full story of the microbiome
https://microbiome.ferring.com/get-the-full-story-of-the-microbiome/
About Ferring Pharmaceuticals | The Power of the Microbiome
http://www.microbiome.ferring.com/about-ferring-pharmaceuticals/
Standard of Care and Predominant Risk Factor 2.0 update
https://microbiome.ferring.com/standard-of-care-and-predominant-risk-factor-2-0-update/
Resources Gut Microbiome and C. Diff Infection | The Power of Microbiome
http://www.microbiome.ferring.com/resources/
Historic Microbiome Restoration Approaches
https://microbiome.ferring.com/historic-microbiome-restoration-approaches/
Approved C. diff Treatment Options | Ferring Pharmaceuticals
https://microbiome.ferring.com/c-difficile-approved-treatment-options/
Dysbiosis and Recurrent C. difficile Infection - Microbiome
https://microbiome.ferring.com/dysbiosis-and-c-diff-infection/

microbiome.ferring.com Httpheader

Server: nginx
Date: Mon, 13 May 2024 10:07:37 GMT
Content-Type: text/html; charset=UTF-8
Content-Length: 112570
Connection: keep-alive
Keep-Alive: timeout=20
Vary: Accept-Encoding, Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
x-powered-by: WP Engine
Link: https://microbiome.ferring.com/wp-json/; rel="https://api.w.org/", https://microbiome.ferring.com/wp-json/wp/v2/pages/4482; rel="alternate"; type="application/json", https://microbiome.ferring.com/; rel=shortlink
X-Cacheable: SHORT
Cache-Control: max-age=600, must-revalidate
Accept-Ranges: bytes
X-Cache: HIT: 8
X-Cache-Group: normal

microbiome.ferring.com Meta Info

charset="utf-8"/
content="width=device-width, initial-scale=1, shrink-to-fit=no" name="viewport"/
content="Recurring c. diff treatment, recurrent c. diff treatment, why does c.diff recur, microbiome restoration, microbiota repopulation, new c. diff drug, why is the human microbiome important, why does c. diff recur, c.diff infection symptoms, c. diff recurrence, signs of c.diff recurrence, causes of c.diff recurrence, human microbiome restoration, what is microbiome, human microbiome, why is the microbiome important." name="keywords"/
content="https://microbiome.ferring.com/wp-content/uploads/2022/11/socialcard.png" itemprop="image" property="og:image"/
content="tfhtjw7uxxfulb9nlvocjie7h7pjc8" name="facebook-domain-verification"
content="index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1" name="robots"
content="Ferring Pharmaceutical educates about the microbiome and if it can be used to break the cycle of recurrent C. difficile (CDI) infection." name="description"
content="en_US" property="og:locale"
content="website" property="og:type"/
content="The Power of the Microbiome | Ferring Pharmaceuticals" property="og:title"/
content="Ferring Pharmaceutical educates about the microbiome and if it can be used to break the cycle of recurrent C. difficile (CDI) infection." property="og:description"/
content="https://microbiome.ferring.com/" property="og:url"/
content="Microbiome" property="og:site_name"/
content="2022-11-15T16:08:46+00:00" property="article:modified_time"/
content="summary_large_image" name="twitter:card"/
content="Est. reading time" name="twitter:label1"/
content="2 minutes" name="twitter:data1"/
content="yes" name="mobile-web-app-capable"/
content="yes" name="apple-mobile-web-app-capable"/
content="Microbiome - Power of Microbiome" name="apple-mobile-web-app-title"/
content="Powered by WPBakery Page Builder - drag and drop page builder for WordPress." name="generator"

microbiome.ferring.com Ip Information

Ip Country: United States
City Name: The Dalles
Latitude: 45.6056
Longitude: -121.1807

microbiome.ferring.com Html To Plain Text

Connect with us REQUEST ADDITIONAL INFORMATION˟ Home The Microbiome Story Importance of Microbial Diversity Dysbiosis and Recurrent C. difficile Infection Currently Approved Treatment Options Historic Microbiome Restoration Approaches Patient and Healthcare Burdens Resources Ferring’s Commitment Home The Microbiome Story Importance of Microbial Diversity Dysbiosis and Recurrent C. difficile Infection Currently Approved Treatment Options Historic Microbiome Restoration Approaches Patient and Healthcare Burdens Resources Ferring’s Commitment Sign Up to Learn More Home Microbiome Phase 2 November is C. diff Awareness Month Ferring is dedicated to helping patients with recurrent C. diff infection live better lives Power of the Microbiome Can It Be Unlocked to Break the Cycle of Recurrent C. difficile Infection? Learn about the microbiome Get the full microbiome story IMPORTANCE OF MICROBIAL DIVERSITY A diverse microbial composition is essential to overall health. Bacteroidetes and Firmicutes , the gut’s most prevalent phyla, are vital to maintaining overall health and inhibiting C. difficile infection. LEARN MORE DYSBIOSIS AND RECURRENT C. DIFFICILE INFECTION Dysbiosis creates an insufficiency of Bacteroidetes and Firmicutes , which may lead to an environment suited for C. difficile growth. LEARN MORE CURRENTLY APPROVED TREATMENT OPTIONS Antibiotic treatment—including vancomycin and fidaxomicin—address the acute infection but do not address (and possibly worsen) dysbiosis or restore the diverse microbial composition—allowing a window of vulnerability for recurrence. LEARN MORE HISTORIC RESTORATION APPROACHES While efficacious, historic approaches to microbiome restoration—including fecal microbiota transplantation and probiotics—have disadvantages. LEARN MORE PATIENT AND HEALTHCARE BURDENS Patients may face significant complications including sepsis, colectomy, and mortality. The healthcare system faces significant challenges including high admission rates, lengths of stays, and care costs. LEARN MORE Mechanism of Disease Microbiome Experts Videos Hear from microbiome content experts discussing everything from disease burden to patient perspectives LEARN MORE Microbiome Restoration—The Limitations of Current Data Microbiome Experts Videos Hear from microbiome content experts discussing everything from disease burden to patient perspectives LEARN MORE Mechanism of CDI EXPLORE THE MICROBIOME LEARN MORE RESOURCES AND TOOLS LEARN MORE SPEAKER PROGRAMS: LEARN FROM THE EXPERTS LEARN MORE Use the menu to view the different sections on the microsite X THE BURDEN OF CDI MAY INCREASE WHEN THE INFECTION RECURS Can the power of the microbiome be unlocked to break the cycle of rCDI? Share this with colleagues! Share #ferringmicrobiome Share this page Privacy Notice Legal Disclaimer Contact Us This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring’s employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring. All information on this site is intended for US audiences only. ©2020 Ferring B.V. US-MBIO-2000006 Speaker Program Sign up Site Map PRIVACY POLICY Legal Disclaimer CONTACT US This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring’s employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring. All information on this site is intended for US audiences only. ©2021 Ferring B.V. US-MBIO-2100090 Home The Microbiome Story Resources Ferring’s COMMITMENT Sign up Site Map PRIVACY POLICY Legal Disclaimer CONTACT US REQUEST ADDITIONAL INFORMATION This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring’s employees and customers, as well as to members of the healthcare community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring. All information on this site is intended for US audiences only. ©2021 Ferring B.V. US-MBIO-2100164 This site is intended for users in the United States. Home The Microbiome Story Resources Ferring’s COMMITMENT Sign up Site Map PRIVACY POLICY Legal Disclaimer CONTACT US REQUEST ADDITIONAL INFORMATION This website provides general information about Ferring in the United States. For information about the global company or its products in another specific country, please select your area of interest under "Ferring Worldwide" above. FERRING, the FERRING PHARMACEUTICALS logo and other Ferring product trade names are trademarks of Ferring B.V. Notwithstanding this disclaimer, all other names and marks mentioned in this website are the trade names, trademarks or service marks of their respective owners. ©2022 Ferring B.V. US-MBIO-2200120 This site is intended for users in the United States. C. DIFF Basics Treating C. DIFF C. DIFF MAY COME BACK Stories & support Sign up PRIVACY POLICY Legal Disclaimer CONTACT US This site contains material about Ferring Pharmaceuticals Inc. (hereinafter Ferring”) and its various products that may be of interest to Ferring’s employees and customers, as well as to members of the healthcare community and the general public. Please feel free to browse this website. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this website, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring. All information on this site is intended for US audiences only. ©2022 Ferring B.V. US-MBIO-2100227 JOIN COMMUNITY Proudly powered by WordPress | Theme: Microbiome US site by understrap.com .(Version: 0.5.5) For...

microbiome.ferring.com Whois

Domain Name: FERRING.COM Registry Domain ID: 1972019_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.comlaude.com Registrar URL: http://www.comlaude.com Updated Date: 2024-02-16T12:26:47Z Creation Date: 1996-10-20T04:00:00Z Registry Expiry Date: 2030-10-19T04:00:00Z Registrar: Nom-iq Ltd. dba COM LAUDE Registrar IANA ID: 470 Registrar Abuse Contact Email: abuse@comlaude.com Registrar Abuse Contact Phone: +442074218250 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited Name Server: FEDC09032VS.FERRING.COM Name Server: FEDC09033VS.FERRING.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T18:39:15Z <<<